Delivery Order SPE2DB20D3505-SPE2DB25FYCCL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,171.80 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10mL) with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL units) with a ceiling value of $13,257.30 under a firm fixed-price contract structure. The award was made on August 11, 2025, with an ultimate completion date of August 12, 2025, and represents a non-set-aside competitive procurement. Performance of the delivery order takes place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) with a ceiling value of $8,721.50 under a Firm Fixed Price contract type. The delivery order, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) with a firm fixed price ceiling value of $7,959.91. The order, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,696.30 for NovoLog 100 Unit/ML vials (10 mL) on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a $1,803.20 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for NovoLog 100 Unit/mL vials (10 mL units). This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) with a ceiling value of $1,361.43 under a firm fixed-price contract awarded on August 7, 2025. The delivery order, which is not set-aside, is scheduled for completion by August 8, 2025, with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This order represents a routine pharmaceutical procurement for insulin supply to support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for supply of NovoLog 100 Unit/mL vials (10mL size) with a ceiling value of $1,506.22. This is a firm fixed price delivery order with no set-aside designation, competitively awarded, and scheduled for completion by August 12, 2025. The order was placed on August 11, 2025, with performance occurring at the vendor's Conshohocken facility....
- The Defense Logistics Agency awarded a delivery order valued at $1,664.69 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of NovoLog 100 Unit/mL vials (10mL). The award is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to...
- The Defense Logistics Agency awarded a delivery order valued at $11,556.16 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction within the federal medical procurement system....
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FYCCLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) with a ceiling value of $1,119.06. The contract, awarded September 2, 2025, with completion by September 3, 2025, utilizes firm fixed price pricing and represents a non-competitive, non-set-aside delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceuticals and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's substantial contract portfolio and competitive history demonstrate its capability to fulfill federal medical supply requirements efficiently across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/2/25 |